7. CEO and founder Dr. Patrick Soon is US biotech royalty.
He sold APP Pharmaceuticals in 2008 for $4.6 billion and Abraxis BioScience in 2010 for about $3 billion.
He was invited by DJT to become health czar in 2017.
He owns 53% of IBRX and has invested $100Ms in $IBRX himself.
$IREN 🔥🔥🔥
🚀 Press the REPOST button if you think IREN will hit $100 this year
🚀🚀 Press the LIKE button if you think IREN will hit $150 this year
🚀🚀 🚀 Press BOTH buttons if you think IREN will hit $200 this year
IREN has now secured 5.8GW of power … AND MUCH MORE TO COME 👀
The big question now is, if/when will IREN and ANTHROPIC do a deal? 👀👀👀
@cucurrata@JuanArnaiz@finallyxpablo Has dicho que lo mataron.
Si no tuvieses la comprensión lectora de un castor entenderías que lo mataron las drogas, no el policía.
Espabila.
@cucurrata@JuanArnaiz@finallyxpablo No te enteras de nada. Le hicieron autopsia, y tenía niveles de fentanilo y metanfetamina compatibles con sobredosis.
@inversormodest1 Te dejas la parte más importante.
$IREN no solo respalda la deuda con las GPUs, sino con toda la infraestructura que posee.
Este es el diferenciador clave con respecto a $CRWV.
@glenchernen@danroberts0101 "Maybe Dan demanded a % of pre ipo Anthropic equity in exchange for what Anthropic needs, and only IREN can deliver, right NOW! 🤔"
🤤🤤🤤🤤🤤
@Bare_Birk@Jonsdahl12 "Fair" is a pretty ambiguous concept haha.
You need to understand that I trully believe that $IREN can become a $1T company in the coming decade.
With that in mind... I'm not selling for less that $500 TODAY.